View More Recent Stories

Aug 27, 2024 09:10AM CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Aug 15, 2024 08:00AM CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 30, 2024 07:05AM CNS Pharmaceuticals (CNSP) Adds Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies

Jul 30, 2024 07:00AM CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies

Jul 25, 2024 09:05AM CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference

Jul 16, 2024 09:15AM CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series

Jul 12, 2024 04:33PM CNS Pharmaceuticals (CNSP) Files for up to 2.4M Share Offering by Selling Stockholders

Jul 3, 2024 11:16AM CNS Pharmaceuticals (CNSP) Prices 1.425M Share Offering at $1.39/sh

Jul 3, 2024 11:10AM CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

Jun 26, 2024 08:03AM CNS Pharmaceuticals (CNSP) Prices Share and Warrant Offering at $2.45/sh

Jun 26, 2024 08:00AM CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

Jun 14, 2024 03:13PM CNS Pharmaceuticals (CNSP) Prices Registered Direct Offering and Concurrent Private Placement

Jun 14, 2024 03:11PM CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

View More Recent Stories